Merck & Co., Inc. is 126.0x more valuable than Prestige Consumer Healthcare Inc. by market capitalization ($293.16 B vs $2.33 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PBH | MRK |
|---|---|---|
| Market cap | $2.33 B | $293.16 B |
| US-listed rank | #1987 | #44 |
| Revenue (latest FY) | $1.09B | $65.01B |
| Net income (latest FY) | $190.30M | $18.25B |
| Net margin | 17.5% | 28.1% |
| P/E (trailing FY) | 12.2 | 16.1 |
| SEC filings | 1,235 | 996 |
Merck & Co., Inc. is 126.0x more valuable than Prestige Consumer Healthcare Inc. by market capitalization ($293.16 B vs $2.33 B).
In their latest fiscal years, Prestige Consumer Healthcare Inc. reported $1.09B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Prestige Consumer Healthcare Inc. and Merck & Co., Inc., or browse the full rankings.